Start a Project based on an existing Technology, or collaborate on new research.
-
Combination of amphiphilic amine (RC16) and oHSV-rQT3 for neuroblastoma treatment
Evaluate the synergistic antitumor effects of RC16 and oHSV combination.
Tags: cancer immunotherapy amphiphilic virus amineCategory: Open Projects5 members -
Develop a new platform for screening therapeutic targets against cancer cells
A screening system to identify potential therapeutic targets for cancer.
Tag: biopharmaCategory: Open Projects6 members -
Efficacy of oHSV
Test the efficacy of oHSV for killing glioblastoma cancer cells.
Category: Open Projects3 members -
Enteric E.coli essential proteins
Develop potential antibiotics that disrupt the essential proteins of enteric E. coli.
Category: Open Projects6 members -
Essential proteins of Pseudomonas aeruginosa
Identified novel antibiotic targets against Pseudomonas aeruginosa.
Category: Open Projects6 members -
Fenretinide for childhood DIPG
Fenretinide used in childhood DIPG tumors
Category: Open Projects2 members -
Fenretinide + oHSV + RC16 as a new therapeutic treatment for cancer
Fenretinide may improve the ability of the virus to enter the cells. The triple combination may work on the tumor by different mechanisms of action probably increasing the therapeutic response.
Category: Open Projects4 members -
Fenretinide (RC16) Cancer Treatment
Test the safety and efficacy of RC16 for cancer treatment.
Tags: cancer amines amphiphilicCategory: Open Projects5 members -
GeRM for Pseudomonas aeruginosa
Develop GeRM to protect the usage of bioengineered Pseudomonas aeruginosa
Category: Open Projects3 members -
oncolytic herpes simplex virus (oHSV)-rQT3 for breast cancer treatment
Research pending.
Category: Open Projects3 members -
oncolytic herpes simplex virus (oHSV)-rQT3 for cholesteatoma treatment
Develop oHSV with armed gene TIMP3 as a novel cholesteatoma therapy.
Tags: MMP ViruBot TPC3 oncolytics cancer immunotherapyCategory: Open Projects5 members -
oncolytic herpes simplex virus (oHSV)-rQT3 for neuroblastoma treatment
This project proposes to develop an oncolytic herpes simplex virus (oHSV) that expresses human tissue inhibitor of metalloproteinases 3 (TIMP3), for treatment of neuroblastoma cancer.
Tag: cancerCategory: Open Projects3 members -
Preclinical study of oHSV-Gluc for cancer screening
Cancer screening via oHSV-Gluc delivered secretable biomarker.
Tags: cancer Biomarkers biopharmaCategory: Open Projects3 members -
Proteome AntiCancers to identify potential therapeutic target for cancer treatment
Use Proteome AntiCancers to screen and identify potential targets against cancer cells.
Category: Open Projects4 members